Laplace Man Indicted for Violating the Federal Controlled Substances Act

1 min read
FILE PHOTO: Signage is seen at the United States Department of Justice headquarters in Washington, D.C.

NEW ORLEANS, LOUISIANA – LENDELL WALLACE, age 38, a resident of Laplace, Louisiana, was charged June 23, 2022, in a two-count indictment by a federal grand jury with conspiracy to possess with intent to distribute tramadol and possession with intent to distribute tramadol in violation of Title 21, United States Code, Sections 846, 841(a)(1), and 841(b)(1)(E), announced U.S. Attorney Duane A. Evans.

The maximum punishment WALLACE faces for each offense is five (5) years imprisonment, a fine of up to $250,000, at least one (1) year of supervised release following any term of imprisonment, and a $100 mandatory special assessment fee.

U.S. Attorney Evans reiterated that the indictment is merely a charging document and that the guilt of the defendant must be proven beyond a reasonable doubt.

This case was investigated by St. John the Baptist Parish Sheriff’s Office, Homeland Security Investigations, United States Postal Inspection Service, and United States Customs and Border Protection. The prosecution is being handled by Assistant United States Attorney J. Benjamin Myers.